Schedule 13G ownership disclosure

Timber Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 887080109

Event date: 2020-05-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,185,605
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-005292
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
May 29, 2020
Reporting period
May 19, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub